Zoi offers a hybrid physical-and-digital preventive care service: members subscribe, visit Zoi health centers for blood tests and checks (vision, hearing, heart, etc.), and receive personalized insights via a mobile app. The company uses data science to build predictive algorithms and applies behavioral 'nudge' techniques to encourage healthier choices. Zoi plans to open its first clinic by the end of the year and will run a testing phase before scaling to larger patient volumes. The founders position the product as an alternative to expensive Paris checkup centers, aiming to be somewhat cheaper and to lower prices over time through economies of scale. At launch the subscription is expected to be relatively expensive and not covered by France’s national healthcare system, and the company acknowledges potential equity concerns. The founding team includes co-founders Ismaël Emelien and Paul Dupuy, ex‑Talend CTO/CPO Cédric Carbone and Fabrice Bonan, and Dr Claude Dalle as chief scientific advisor. Zoi says it will expand beyond Paris after initial rollout.

Total raised

$23M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2022